Abstract
Gender differences in prevalence, manifestation, treatment outcomes, and prognosis have been well known for acquired heart disease such as coronary artery disease. Regarding congenital heart disease (CHD), it is recognized that the incidence of each congenital heart defect varies according to sex observed during a time span of more than 40 years. As diagnostic and surgical methods for CHD have achieved dramatic advances for the past decades, more newborns with CHD were able to survive and reach adulthood. Thereafter gender differences have begun to be reported on mortality, progress to pulmonary arterial hypertension, treatment outcomes, and prognosis in patients with CHD. However, it has been less known in the field of CHD yet, and this contribution describes information that is relatively well studied to date.
Epidemiology of congenital heart disease. Art work by Piet Michiels, Leuven, Belgium
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Rothman KJ, Fyler DC. Sex, birth order, and maternal age characteristics of infants with congenital heart defects. Am J Epidemiol. 1976;104:527–34.
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.
Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163–72.
Egbe A, Uppu S, Stroustrup A, Lee S, Ho D, Srivastava S. Incidences and sociodemographics of specific congenital heart diseases in the United States of America: an evaluation of hospital discharge diagnoses. Pediatr Cardiol. 2014;35:975–82.
Yeh SJ, Chen HC, Lu CW, Wang JK, Huang LM, Huang SC, et al. Prevalence, mortality, and the disease burden of pediatric congenital heart disease in Taiwan. Pediatr Neonatol. 2013;54:113–8.
Qu Y, Liu X, Zhuang J, Chen G, Mai J, Guo X, et al. Incidence of congenital heart disease: The 9-year experience of the Guangdong Registry of Congenital Heart Disease, China. PLoS One. 2016;11:e0159257. https://doi.org/10.1371/journal.pone.0159257.
Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of cardiovascular malformations. Heart. 2000;83:414–9.
Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. National time trends in congenital heart defects, Denmark, 1977–2005. Am Heart J. 2009;157:467–73.
Fixler DE, Pastor P, Chamberlin M, Sigman E, Eifler CW. Trends in congenital heart disease in Dallas County births. 1971–1984. Circulation. 1990;81:137–42.
van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:2241–7.
Pradat P, Francannet C, Harris JA, Robert E. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol. 2003;24:195–221.
Calzolari E, Garani G, Cocchi G, Magnani C, Rivieri F, Neville A, et al. Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidemiol. 2003;18:773–80.
Egbe A, Uppu S, Lee S, Stroustrup A, Ho D, Srivastava S. Temporal variation of birth prevalence of congenital heart disease in the United States. Congenit Heart Dis. 2015;10:43–50.
Moons P, Sluysmans T, De Wolf D, Massin M, Suys B, Benatar A, et al. Congenital heart disease in 111 225 births in Belgium: birth prevalence, treatment and survival in the 21st century. Acta Paediatr. 2009;98:472–7.
Liebson PR. Cardiovascular risk in special populations IV: congenital heart defects. Prev Cardiol. 2010;13:49–55.
Aubry P, Demian H. Sex differences in congenital heart disease. Ann Cardiol Angeiol (Paris). 2016;65:440–5.
McBride KL, Marengo L, Canfield M, Langlois P, Fixler D, Belmont JW. Epidemiology of noncomplex left ventricular outflow tract obstruction malformations (aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome) in Texas, 1999–2001. Birth Defects Res A Clin Mol Teratol. 2005;73:555–61.
Michalski AM, Richardson SD, Browne ML, Carmichael SL, Canfield MA, Van Zutphen AR, et al. Sex ratios among infants with birth defects, National Birth Defects Prevention Study, 1997–2009. Am J Med Genet. 2015;167A:1071–81.
Shaw GM, Carmichael SL, Kaidarova Z, Harris JA. Differential risks to males and females for congenital malformations among 2.5 million California births, 1989–1997. Birth Defects Res A Clin Mol Teratol. 2003;67:953–8.
Sokal R, Tata LJ, Fleming KM. Sex prevalence of major congenital anomalies in the United Kingdom: a national population-based study and international comparison meta-analysis. Birth Defects Res A Clin Mol Teratol. 2014;100:79–91.
Tennant PWG, Samarasekera SD, Pless-Mulloli T, Rankin J. Sex differences in the prevalence of congenital anomalies: a population-based study. Birth Defects Res A Clin Mol Teratol. 2011;91:894–901.
Warnes CA. Sex differences in congenital heart disease: should a woman be more like a man? Circulation. 2008;118:3–5.
Warnes CA. Bicuspid aortic valve and coarctation: two villains part of a diffuse problem. Heart. 2003;89:965–6.
Duffels MGJ, Engelfriet PM, Berger RMF, van Loon RLE, Hoendermis E, Vriend JWJ, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol. 2007;120:198–204.
Klitzner TS, Lee M, Rodriguez S, R-KR C. Sex-related disparity in surgical mortality among pediatric patients. Congenit Heart Dis. 2006;1:77–88.
Somerville J. The Denolin Lecture: the woman with congenital heart disease. Eur Heart J. 1998;19:1766–75.
Shapiro S, Traiger GL, Turner M, McGoon MD, Wason P, Barst RJ. Sex differences in the diagnosis, treatment and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Chest. 2012;141:363–73.
Marelli A, Gauvreau K, Landzberg M, Jenkins K. Sex differences in mortality in children undergoing congenital heart disease surgery. A United States population-based study. Circulation. 2010;122(Suppl. 1):S234–40.
Harvey RE, Coffman KE, Miller VM. Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Womens Health (Lond). 2015;11:239–57.
Lee HW, Eghbali-Webb M. Estrogen enhances proliferative capacity of cardiac fibroblasts by estrogen receptor- and mitogen-activated protein kinase-dependent pathways. J Mol Cell Cardiol. 1998;30:1359–68.
Fyler DC. Report of the New England regional infant cardiac program. Pediatrics. 1980;65:375–461.
DiBardino DJ, Pasquali SK, Hirsch JC, Benjamin DK, Kleeman KC, Sala-zar JD, et al. Effect of sex and race on outcome in patients undergoing congenital heart surgery: an analysis of the Society of Thoracic Surgeons Congenital Heart database. Ann Thorac Surg. 2012;94:2054–9.
Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Vliegen HW, et al. Gender and outcome in adult congenital heart disease. Circulation. 2008;118:26–32.
Engelfriet P, Mulder BJM. Gender differences in adult congenital heart disease. Neth Heart J. 2009;17:414–7.
Zomer CA, Ionescu-Ittu R, Vaartjes I, Pilote L, Mackie AS, Therrien J, et al. Sex differences in hospital mortality in adults with congenital heart disease. The impact of reproductive health. J Am Coll Cardiol. 2013;62:58–67.
Sarikouch S, Boethig D, Peters B, Kropf S, Dubowy KO, Lange P, et al. Poorer right ventricular systolic function and exercise capacity in women after repair of tetralogy of Fallot: a sex comparison of standard deviation scores based on sex-specific reference values in healthy control subjects. Circ Cardiovasc Imaging. 2013;6:924–33.
Egidy Assenza G, Cassater D, Landzberg M, Geva T, Schreier J, Graham D, et al. The effects of pregnancy on right ventricular remodeling in women with repaired tetralogy of Fallot. Int J Cardiol. 2013;168:1847–52.
Sarikouch S, Koerperich H, Dubowy KO, Boethig D, Boettler P, Mir TS, et al. Impact of gender and age on cardiovascular function late after repair of tetralogy of Fallot: percentiles based on cardiac magnetic resonance. Circ Cardiovasc Imaging. 2011;4:703–11.
Kerkhof PLM, van de Ven PM, Yoo BW, Peace RA, Heyndrickx GR, Handly N. Ejection fraction as related to basic components in the left and right ventricular volume domains. Int J Cardiol. 2018;255:105–10.
Kuipers JM, van der Bom T, van Riel ACMJ, Meijboom FJ, van Dijk APJ, Pieper PG, et al. Secundum atrial septal defect is associated with reducedsurvival in adult men. Eur Heart J. 2015;36:2079–86.
Yoo BW, Kim JO, Kim YJ, Choi JY, Park HK, Park YH, et al. Impact of pressure load caused by right ventricular outflow tract obstruction on right ventricular volume overload in patients with repaired tetralogy of Fallot. J Thorac Cardiovasc Surg. 2012;143:1299–304.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Yoo, B.W. (2018). Epidemiology of Congenital Heart Disease with Emphasis on Sex-Related Aspects. In: Kerkhof, P., Miller, V. (eds) Sex-Specific Analysis of Cardiovascular Function. Advances in Experimental Medicine and Biology, vol 1065. Springer, Cham. https://doi.org/10.1007/978-3-319-77932-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-77932-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77931-7
Online ISBN: 978-3-319-77932-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)